Sunita KS Singh
University Health Network, Toronto General Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Sunita KS Singh as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:38 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT05715814 · meChANisms and sAfety of SGLT2 Inhibition in peRitoneal dialYsisUniversity Health Network, Toronto · recruiting · Peritoneal Dialysis Complication, End Stage Kidney Disease, Sodium-glucose Co-transporter-2 Inhibitors · principal investigator
- Ph3NCT04965935 · Efficacy, Mechanisms and Safety of SGLT2 Inhibitors in Kidney Transplant RecipientsUniversity Health Network, Toronto · completed · Kidney Transplant Recipients, Post-transplant Diabetes Mellitus, Type 2 Diabetes · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:38 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 10:38 UTC. The ranking covers the 200 most relevant of 79 PubMed records, and a shared surname and initials can bring in a namesake. All 79 on PubMed
- 285 citationsRCR 14.9
- Radial artery and saphenous vein patency more than 5 years after coronary artery bypass surgery: results from RAPS (Radial Artery Patency Study).J Am Coll Cardiol · 2012200 citationsRCR 6.4
- Sodium citrate versus heparin catheter locks for cuffed central venous catheters: a single-center randomized controlled trial.Am J Kidney Dis · 2009100 citationsRCR 4.0
- SUPERIOR SVG: no touch saphenous harvesting to improve patency following coronary bypass grafting (a multi-Centre randomized control trial, NCT01047449).J Cardiothorac Surg · 201997 citationsRCR 5.3
- A novel allogeneic off-the-shelf dendritic cell vaccine for post-remission treatment of elderly patients with acute myeloid leukemia.Cancer Immunol Immunother · 201881 citationsRCR 2.6
- Comparison of HoLEP and TURP in terms of efficacy in the early postoperative period and perioperative morbidity.Urol Int · 200961 citationsRCR 2.8
- Pharmacokinetic interaction of chloroquine and methylene blue combination against malaria.Eur J Clin Pharmacol · 200459 citationsRCR 1.6
- 59 citationsRCR 3.1
- The malaria vaccine candidate GMZ2 elicits functional antibodies in individuals from malaria endemic and non-endemic areas.J Infect Dis · 201358 citationsRCR 2.0
- 57 citationsRCR 2.7